Glucagon-Like Peptide-1 Receptor Agonists and Osteoarthritis

被引:1
作者
Felson, David T. [1 ]
机构
[1] Boston Univ, Sch Med, Boston, MA 02215 USA
关键词
WEIGHT-LOSS;
D O I
10.1056/NEJMe2409972
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1643 / 1644
页数:2
相关论文
共 11 条
[1]   Weight loss in obese people has structure-modifying effects on medial but not on lateral knee articular cartilage [J].
Anandacoomarasamy, A. ;
Leibman, S. ;
Smith, G. ;
Caterson, I. ;
Giuffre, B. ;
Fransen, M. ;
Sambrook, P. N. ;
March, L. .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (01) :26-32
[2]   Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis [J].
Bliddal, Henning ;
Bays, Harold ;
Czernichow, Sebastien ;
Hemmingsson, Joanna Udden ;
Hjelmesaeth, Joran ;
Morville, Thomas Hoffmann ;
Koroleva, Anna ;
Neergaard, Jesper Skov ;
Sanchez, Patricia Velez ;
Wharton, Sean ;
Wizert, Alicja ;
Kristensen, Lars E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (17) :1573-1583
[3]   Challenges for Osteoarthritis Trials [J].
Felson, David T. ;
Neogi, Tuhina .
ARTHRITIS & RHEUMATOLOGY, 2018, 70 (08) :1175-1181
[4]   WEIGHT-LOSS REDUCES THE RISK FOR SYMPTOMATIC KNEE OSTEOARTHRITIS IN WOMEN - THE FRAMINGHAM-STUDY [J].
FELSON, DT ;
ZHANG, YQ ;
ANTHONY, JM ;
NAIMARK, A ;
ANDERSON, JJ .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (07) :535-539
[5]   Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial [J].
Hernandez, Adrian F. ;
Green, Jennifer B. ;
Janmohamed, Salim ;
D'Agostino, Ralph B., Sr. ;
Granger, Christopher B. ;
Jones, Nigel P. ;
Leiter, Lawrence A. ;
Rosenberg, Anne E. ;
Sigmon, Kristina N. ;
Somerville, Matthew C. ;
Thorpe, Karl M. ;
McMurray, John J. V. ;
Del Prato, Stefano .
LANCET, 2018, 392 (10157) :1519-1529
[6]   Association of Visceral Adiposity With Pain but Not Structural Osteoarthritis [J].
Li, Shanshan ;
Schwartz, Ann V. ;
Lavalley, Michael P. ;
Wang, Na ;
Desai, Nancy ;
Sun, Xianbang ;
Neogi, Tuhina ;
Nevitt, Michael ;
Lewis, Cora E. ;
Guermazi, Ali ;
Roemer, Frank ;
Segal, Neil ;
Felson, David .
ARTHRITIS & RHEUMATOLOGY, 2020, 72 (07) :1103-1110
[7]   Prevalence Trends of Site-Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019 [J].
Long, Huibin ;
Liu, Qiang ;
Yin, Heyong ;
Wang, Kai ;
Diao, Naicheng ;
Zhang, Yuqing ;
Lin, Jianhao ;
Guo, Ai .
ARTHRITIS & RHEUMATOLOGY, 2022, 74 (07) :1172-1183
[8]   Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis [J].
Meurot, C. ;
Martin, C. ;
Sudre, L. ;
Breton, J. ;
Bougault, C. ;
Rattenbach, R. ;
Bismuth, K. ;
Jacques, C. ;
Berenbaum, F. .
SCIENTIFIC REPORTS, 2022, 12 (01)
[9]   Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations [J].
Sokolove, Jeremy ;
Lepus, Christin M. .
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2013, 5 (02) :77-94
[10]   Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation [J].
Wong, Chi Kin ;
Mclean, Brent A. ;
Baggio, Laurie L. ;
Koehler, Jacqueline A. ;
Hammoud, Rola ;
Rittig, Nikolaj ;
Yabut, Julian M. ;
Seeley, Randy J. ;
Brown, Theodore J. ;
Drucker, Daniel J. .
CELL METABOLISM, 2024, 36 (01) :130-143.e5